Us Bancorp \De\ Shockwave Medical, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$191.17 - $325.63 $100,746 - $171,607	527 Added 53.89%	1,505 $490,000
Q4 2023 Feb 09, 2024	BUY	$160.99 - $215.69 $42,179 - $56,510	262 Added 36.59%	978 $186,000
Q3 2023 Nov 03, 2023	BUY	$194.33 - $283.97 $777 - $1,135	4 Added 0.56%	716 $142,000
Q2 2023 Aug 09, 2023	SELL	$223.05 - $302.68 $788,704 - $1.07 Million	-3,536 Reduced 83.24%	712 $203,000
Q1 2023 May 09, 2023	BUY	$175.41 - $217.92 $25,259 - $31,380	144 Added 3.51%	4,248 $921,000
Q4 2022 Feb 13, 2023	BUY	$204.38 - $296.82 $97,489 - $141,583	477 Added 13.15%	4,104 $843,000
Q3 2022 Oct 27, 2022	SELL	$195.21 - $310.53 $1 Million - $1.6 Million	-5,137 Reduced 58.61%	3,627 $1.01 Million
Q2 2022 Aug 01, 2022	BUY	$115.91 - $214.48 $259,406 - $480,006	2,238 Added 34.29%	8,764 $1.68 Million
Q1 2022 May 11, 2022	BUY	$127.96 - $207.36 $653,363 - $1.06 Million	5,106 Added 359.58%	6,526 $1.35 Million
Q4 2021 Feb 11, 2022	SELL	$165.13 - $241.83 $29,558 - $43,287	-179 Reduced 11.19%	1,420 $253,000
Q3 2021 Nov 10, 2021	SELL	$163.99 - $235.57 $11,151 - $16,018	-68 Reduced 4.08%	1,599 $328,000
Q2 2021 Aug 05, 2021	BUY	$131.45 - $201.49 $20,111 - $30,827	153 Added 10.11%	1,667 $316,000
Q1 2021 Apr 28, 2021	BUY	$92.73 - $142.05 $14,651 - $22,443	158 Added 11.65%	1,514 $197,000
Q4 2020 Feb 04, 2021	BUY	$67.44 - $103.72 $46,533 - $71,566	690 Added 103.6%	1,356 $141,000
Q3 2020 Nov 10, 2020	BUY	$42.79 - $75.8 $5,605 - $9,929	131 Added 24.49%	666 $51,000
Q2 2020 Aug 07, 2020	SELL	$27.25 - $47.53 $20,464 - $35,695	-751 Reduced 58.4%	535 $26,000
Q1 2020 May 13, 2020	BUY	$23.16 - $47.74 $29,783 - $61,393	1,286 New	1,286 $43,000

Others Institutions Holding SWAV

# of Institutions

Shares Held

321K

Call Options Held

1.9K

Put Options Held

View Full List

About Shockwave Medical, Inc.

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

More about SWAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account